Although autophagy has been proposed as a mechanism of Id1 degradation in neuroblastoma cells [38], our data indicate that the autophagy inhibitor CQ does not affect the trametinib-mediated Id1 downregulation in KRAS-mutant LUAD cells. Here, ID1 is linked to neuroblastoma.